Home|Journals|Articles by Year|Audio Abstracts

Original Research

The predictive value of platelet to lymphocyte ratio for procedural complications and mid-term mortality in aortic stenosis patients who underwent a transcatheter aortic valve implantation

Aydin Rodi Tosu, Tufan Cinar, Arda Guler, Serkan Kahraman, Ismail Gurbak.

Cited by 3 Articles

Aim: Calcific aortic valve disease is an active cellular process including chronic inflammation, calcification, and lipid accumulation which issimilar to atherosclerosis. The platelet to lymphocyte ratio (PLR) is a hematologicalparameter which increases with the inflammation and vascular oxidative stress. In the present study, we aimed to evaluate whether the PLR had a prognostic role inprocedural complications and mid-term mortality ofaortic stenosis (AS) patients underwent transcatheter aortic valve implantation (TAVI).
Material and Methods: A total of 100 symptomatic severe AS patients undergone TAVI in atertiary heart center between June 2012 and June 2016 were retrospectively analyzed. The PLR was calculated by dividing the absolute platelet count by the absolute lymphocyte count before the TAVI procedure. The follow-up duration of the study was six months.
Results: The mean age of study population was 78 years (range: 65-85), and 35 patients were male. Of note, serum PLR level was significantly elevated in patients who developed vascular complication and stroke after the TAVI (p

Key words: Trans-Aortic Valve Implantation, Platelet To Lymphocyte Ratio, Inflammation, Mortality, Stroke, Vascular Complication.

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.